A Study of Patients With Fabry Disease (US Specific)
Public ClinicalTrials.gov record NCT06906367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Observational Study of Patients With Fabry Disease (US Specific)
Study identification
- NCT ID
- NCT06906367
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Amicus Therapeutics
- Industry
- Enrollment
- 450 participants
Conditions and interventions
Conditions
Interventions
- ERT Drug
- migalastat HCl Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 12, 2026
- Primary completion
- May 31, 2032
- Completion
- May 31, 2032
- Last update posted
- Apr 27, 2026
2026 – 2032
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Nephrology Research Clinic at Paula Building | Birmingham | Alabama | 35233 | Not yet recruiting |
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | Recruiting |
| Emory Genetics | Atlanta | Georgia | 30322 | Recruiting |
| Washington University School of Medicine | St Louis | Missouri | 63110 | Not yet recruiting |
| New York-Presbyterian Morgan Stanley Children's Hospital - Columbia University Medical Center | New York | New York | 10032 | Not yet recruiting |
| UPMC Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania | 15224 | Not yet recruiting |
| Renal Disease Research Institute | Dallas | Texas | 75204 | Recruiting |
| Lysosomal and Rare Disorders Research and Treatment Center, Inc. | Fairfax | Virginia | 22030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06906367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06906367 live on ClinicalTrials.gov.